220 related articles for article (PubMed ID: 32606957)
1. Synergistic Anticancer Effects of Gemcitabine with Pitavastatin on Pancreatic Cancer Cell Line MIA PaCa-2 in vitro and in vivo.
Chen YH; Chen YC; Lin CC; Hsieh YP; Hsu CS; Hsieh MC
Cancer Manag Res; 2020; 12():4645-4665. PubMed ID: 32606957
[TBL] [Abstract][Full Text] [Related]
2. Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo.
DeRosier LC; Huang ZQ; Sellers JC; Buchsbaum DJ; Vickers SM
J Gastrointest Surg; 2006 Nov; 10(9):1291-300; discussion 1300. PubMed ID: 17114015
[TBL] [Abstract][Full Text] [Related]
3. Heptadecanoic Acid, an Odd-Chain Fatty Acid, Induces Apoptosis and Enhances Gemcitabine Chemosensitivity in Pancreatic Cancer Cells.
Kim HY; Moon JY; Cho SK
J Med Food; 2023 Mar; 26(3):201-210. PubMed ID: 36716276
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Anti-tumor Effect of Flavopiridol in Combination With Gemcitabine in Pancreatic Cancer.
Chung KH; Cho IR; Paik WH; Kim YT; Lee SH; Ryu JK
Anticancer Res; 2024 Mar; 44(3):1097-1108. PubMed ID: 38423644
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable nanocarrier of gemcitabine and tocopherol succinate synergistically ameliorates anti-proliferative response in MIA PaCa-2 cells.
Behera C; Kaur Sandha K; Banjare N; Kumar Shukla M; Mudassir Ali S; Singh M; Gupta PN
Int J Pharm; 2024 Jan; 649():123599. PubMed ID: 37992978
[TBL] [Abstract][Full Text] [Related]
6. Pitavastatin and metformin synergistically activate apoptosis and autophagy in pancreatic cancer cells.
Chen YH; Huang YC; Yang SF; Yen HH; Tsai HD; Hsieh MC; Hsiao YH
Environ Toxicol; 2021 Aug; 36(8):1491-1503. PubMed ID: 33886150
[TBL] [Abstract][Full Text] [Related]
7. Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines.
Morimoto Y; Takeuchi O; Takizawa A; Yoneyama H; Asanuma F; Suzuki Y; Atsuda K; Yamada Y
Anticancer Drugs; 2012 Jun; 23(5):505-14. PubMed ID: 22334000
[TBL] [Abstract][Full Text] [Related]
8. Intracellular Cytidine Deaminase Regulates Gemcitabine Metabolism in Pancreatic Cancer Cell Lines.
Bjånes TK; Jordheim LP; Schjøtt J; Kamceva T; Cros-Perrial E; Langer A; Ruiz de Garibay G; Kotopoulis S; McCormack E; Riedel B
Drug Metab Dispos; 2020 Mar; 48(3):153-158. PubMed ID: 31871136
[TBL] [Abstract][Full Text] [Related]
9. Effects of lorglumide on growth and invasion of human pancreatic cancer cell line Mia PaCa-2 in vitro through the cholecystokinin-cholecystokinin-1 receptor pathway.
Zhou J; Zhang ZX; Li DC
Curr Ther Res Clin Exp; 2010 Aug; 71(4):239-51. PubMed ID: 24688146
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells.
Duong HQ; Hwang JS; Kim HJ; Kang HJ; Seong YS; Bae I
Int J Oncol; 2012 Sep; 41(3):855-61. PubMed ID: 22710732
[TBL] [Abstract][Full Text] [Related]
11. [Effect of Hematopoietic Pre-B-cell Leukemia Transcription Factor Interacting Protein Knockdown on Proliferation,Cell Cycle and Apoptosis in Pancreatic Cancer Cells].
Zhao YM; Yang G; You L; Hu Y; Zhao YP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):7-15. PubMed ID: 32131934
[No Abstract] [Full Text] [Related]
12. Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone.
Prashanth N ; Meghana P ; Sandeep Kumar Jain R ; Pooja S Rajaput ; Satyanarayan N D ; Raja Naika H ; Kumaraswamy H M
Sci Total Environ; 2024 Mar; 914():169727. PubMed ID: 38163613
[TBL] [Abstract][Full Text] [Related]
13. Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2.
Kato S; Shirato K; Imaizumi K; Toyota H; Mizuguchi J; Odawara M; Che XF; Akiyama S; Abe A; Tomoda A
Oncol Rep; 2006 Apr; 15(4):843-8. PubMed ID: 16525669
[TBL] [Abstract][Full Text] [Related]
14. The flavonoid p-hydroxycinnamic acid exhibits anticancer effects in human pancreatic cancer MIA PaCa-2 cells in vitro: Comparison with gemcitabine.
Yamaguchi M; Murata T; El-Rayes BF; Shoji M
Oncol Rep; 2015 Dec; 34(6):3304-10. PubMed ID: 26397991
[TBL] [Abstract][Full Text] [Related]
15. CNT1 expression influences proliferation and chemosensitivity in drug-resistant pancreatic cancer cells.
Bhutia YD; Hung SW; Patel B; Lovin D; Govindarajan R
Cancer Res; 2011 Mar; 71(5):1825-35. PubMed ID: 21343396
[TBL] [Abstract][Full Text] [Related]
16. Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells.
Nishikubo K; Ohgaki R; Liu X; Okanishi H; Xu M; Endou H; Kanai Y
Cancer Cell Int; 2023 Jun; 23(1):116. PubMed ID: 37322479
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of HMJ-38, a new quinazolinone analogue, against the gemcitabine-resistant MIA-PaCa-2 pancreatic cancer cells.
Hour MJ; Tsai FJ; Lai IL; Tsao JW; Chiang JH; Chiu YJ; Lu HF; Juan YN; Yang JS; Tsai SC
Biomedicine (Taipei); 2023; 13(4):20-31. PubMed ID: 38532833
[TBL] [Abstract][Full Text] [Related]
18. [MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].
Sun Y; Jin XL; Zhang TT; Jia CW; Chen J
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):460-4. PubMed ID: 24246865
[TBL] [Abstract][Full Text] [Related]
19. Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53.
Yadav V; Sultana S; Yadav J; Saini N
PLoS One; 2012; 7(10):e47796. PubMed ID: 23133524
[TBL] [Abstract][Full Text] [Related]
20. Combined pitavastatin and dacarbazine treatment activates apoptosis and autophagy resulting in synergistic cytotoxicity in melanoma cells.
Al-Qatati A; Aliwaini S
Oncol Lett; 2017 Dec; 14(6):7993-7999. PubMed ID: 29344241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]